← Back to Search

Video-Based HIV Test Information for Spanish-Speaking Latinos with HIV/AIDS

Phase 3
Waitlist Available
Led By Dr. Roland Merchant, MD, MPH, ScD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-64 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will test whether a video on HIV and HIV tests is as effective as an in-person presentation with an HIV test counselor in delivering information to Spanish-speaking HIV test recipients.

Who is the study for?
This trial is for Spanish-speaking Latinos aged 18-64 who can consent to participate. It's not suitable for those with severe visual or hearing impairments, prisoners, the critically ill, intoxicated individuals, those treated for acute psychiatric illnesses, mentally incapacitated persons, or participants in HIV vaccine trials.Check my eligibility
What is being tested?
The study is testing if a video in Spanish about HIV and its testing methods is as effective as getting this information from an in-person counselor. Participants will receive either the video or live presentation.See study design
What are the potential side effects?
Since this trial involves informational videos and presentations rather than medical treatments, there are no direct side effects associated with the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 64 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of an educational video regarding HIV and HIV testing for Spanish speaking Latinos

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Video PresentationExperimental Treatment1 Intervention
Participants will watch an HIV and HIV testing video
Group II: In Person CounselingActive Control1 Intervention
Participants will receive an in person HIV and HIV testing counseling session

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
257 Previous Clinical Trials
70,784 Total Patients Enrolled
8 Trials studying Acquired Immunodeficiency Syndrome
2,680 Patients Enrolled for Acquired Immunodeficiency Syndrome
Dr. Roland Merchant, MD, MPH, ScDPrincipal InvestigatorRhode Island Hospital

Media Library

Video or In-Person Presentation Clinical Trial Eligibility Overview. Trial Name: NCT01452555 — Phase 3
Acquired Immunodeficiency Syndrome Research Study Groups: In Person Counseling, Video Presentation
Acquired Immunodeficiency Syndrome Clinical Trial 2023: Video or In-Person Presentation Highlights & Side Effects. Trial Name: NCT01452555 — Phase 3
Video or In-Person Presentation 2023 Treatment Timeline for Medical Study. Trial Name: NCT01452555 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we excluding elderly patients from this experiment?

"This particular clinical trial is only testing people aged 18 to 64. If you don't fit this age bracket, there are still 63 other trials testing minors and 183 trials testing seniors."

Answered by AI

Has the FDA cleared either Video or In-Person Presentation for use?

"There is some data to support the efficacy of a Video or In-Person Presentation, and it has received a score of 3 on the Power safety scale."

Answered by AI
~15 spots leftby Mar 2025